Clinical trial
Raloxifene and Rimostil for Perimenopause-Related Depression
NCT00030147 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00030147 |
|---|---|
| Title | Raloxifene and Rimostil for Perimenopause-Related Depression |
| Official title | The Efficacy of Phytoestrogens and Selective Estrogen Receptor Modulators in Perimenopause-Related Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Perimenopausal Depression, Depression |
| Intervention type | Drug |
| Interventions | Raloxifene, Rimostil, Transdermal Estradiol, Placebo skin patch and placebo tablets |
| Enrollment | 65 |
| Start date | Feb 1, 2002 |
| Primary completion | Jun 1, 2015 |
| Completion | Jun 1, 2015 |
| First posted | Feb 7, 2002 |
| Last update posted | Sep 5, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: